Navigation Links
Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Date:9/12/2017

DrugDev, a QuintilesIMS company, continues to strengthen its position as the clinical technology provider for small to mid-size biotechs and pharma worldwide with continued adoption of the DrugDev Spark™ unified clinical trial suite.

Sponsors unfamiliar with DrugDev Spark can experience solutions for site selection and activation, eConsent, site payments and site engagement with hands-on technology demonstrations and best practice discussions at a series of educational “Clinical Coffee” events. Register here to attend the live session scheduled for September 27 from 9am-12pm ET in Parsippany, New Jersey.

DrugDev’s growth has come as a result of proven success improving clinical trials across therapeutic areas with sponsors of all sizes in addition to Top 20 global pharmaceutical clients.

Watch a rare disease webinar with Alnylam and AMO Pharma discussing how to use technology to design and conduct more efficient and effective clinical research.

“Clinical innovation isn’t reserved exclusively for Top 20 Pharma trying to build their brand as a sponsor of choice,” said DrugDev Chief Commercial Officer Brett Kleger. “Increasingly, smaller pharmas and biotechs are adopting DrugDev Spark to improve site relationships and productivity, elevate their CRO, and support internal study teams with efficient automation tools. Scalable technology like ours is flexible enough for any budget, and levels the playing field for smaller sponsors and biotechs worldwide.”

To learn how DrugDev Spark is changing the game for smaller pharmaceutical companies, begin a conversation or request a demo at http://www.drugdev.com.

About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14677792.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services To Meet Pharmaceutical Industry Demand
2. Franz's Allegro Common Lisp Meets Demand for High Performance Artificial Intelligence and IoT Applications
3. Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand
4. Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
5. SSCI Expands Biochemistry Services to Meet Growing Industry Demand
6. CohBar Inc. Presentation Now Available for On-Demand Viewing
7. SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand
8. Continuous Flow Chemistry Methods Revealed in On-Demand Webinars from METTLER TOLEDO
9. Demand of Amyloglucosidase Market to 2020 Analysed with Sales, Manufacture Share and Type
10. Chi-Med webcast presentation now available for on-demand viewing: Deutsche Bank ADR Virtual Investor Conference
11. Global Biomaterials Market - By Type, Application, Regions - Market Size, Demand Forecasts, Industry Trends and Updates (2014- 2020)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:8/15/2017)... --  ivWatch LLC , a medical device company focused on improving ... of its ISO 13485 Certification, the global standard for medical device ... (ISO®). ... Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
Breaking Biology News(10 mins):